End-of-day quote
MACEDONIAN S.E.
|
- MKD
|
-
|
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
9,783
|
11,103
|
12,132
|
12,794
|
14,289
|
16,513
|
EBITDA
1 |
1,411
|
1,586
|
1,889
|
1,986
|
2,207
|
2,506
|
EBIT
1 |
1,044
|
1,176
|
1,447
|
1,468
|
1,649
|
1,908
|
Operating Margin
|
10.67%
|
10.59%
|
11.92%
|
11.48%
|
11.54%
|
11.55%
|
Earnings before Tax (EBT)
1 |
968.8
|
1,188
|
1,328
|
1,457
|
1,644
|
1,786
|
Net income
1 |
862.4
|
1,015
|
1,168
|
1,302
|
1,463
|
1,577
|
Net margin
|
8.82%
|
9.14%
|
9.62%
|
10.18%
|
10.24%
|
9.55%
|
EPS
2 |
608.8
|
717.5
|
828.7
|
926.4
|
1,041
|
1,122
|
Free Cash Flow
1 |
674.8
|
248.1
|
-151.3
|
533.4
|
93.91
|
324.1
|
FCF margin
|
6.9%
|
2.23%
|
-1.25%
|
4.17%
|
0.66%
|
1.96%
|
FCF Conversion (EBITDA)
|
47.82%
|
15.65%
|
-
|
26.86%
|
4.26%
|
12.93%
|
FCF Conversion (Net income)
|
78.24%
|
24.44%
|
-
|
40.96%
|
6.42%
|
20.55%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/27/19
|
4/6/20
|
4/5/21
|
10/31/22
|
4/3/23
|
4/1/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
154
|
422
|
905
|
960
|
1,202
|
1,402
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.1094
x
|
0.2662
x
|
0.4791
x
|
0.4833
x
|
0.5449
x
|
0.5593
x
|
Free Cash Flow
1 |
675
|
248
|
-151
|
533
|
93.9
|
324
|
ROE (net income / shareholders' equity)
|
9.47%
|
10.5%
|
11%
|
11.5%
|
12.1%
|
12%
|
ROA (Net income/ Total Assets)
|
5.6%
|
5.84%
|
6.32%
|
5.81%
|
6.16%
|
6.35%
|
Assets
1 |
15,388
|
17,398
|
18,469
|
22,399
|
23,760
|
24,825
|
Book Value Per Share
2 |
6,596
|
7,303
|
7,742
|
8,292
|
8,899
|
9,812
|
Cash Flow per Share
2 |
306.0
|
254.0
|
238.0
|
353.0
|
204.0
|
333.0
|
Capex
1 |
866
|
871
|
1,447
|
1,211
|
1,222
|
1,324
|
Capex / Sales
|
8.85%
|
7.84%
|
11.93%
|
9.46%
|
8.55%
|
8.02%
|
Announcement Date
|
8/27/19
|
4/6/20
|
4/5/21
|
10/31/22
|
4/3/23
|
4/1/24
|
|
1st Jan change
|
Capi.
|
---|
| 0.00% | 0 | | +19.62% | 43.34B | | +20.44% | 21.96B | | +10.86% | 14.09B | | +13.07% | 13.64B | | +37.46% | 11.43B | | -8.59% | 6.86B | | -0.05% | 6.79B | | -8.87% | 5.73B | | +8.46% | 5.22B |
Generic Pharmaceuticals
|